Impaired thrombolysis: a novel cardiovascular risk factor in end-stage renal disease

Sumeet Sharma; Ken Farrington; Robert Kozarski; Christos Christopoulos; Maria  Niespialowska-Steuden; Daniel  Moffat; Diana Gorog

doi:10.1093/eurheartj/ehs300

Impaired thrombolysis: a novel cardiovascular risk factor in end-stage renal disease

Sumeet Sharma
, Ken Farrington
, Robert Kozarski
, Christos Christopoulos
, Maria Niespialowska-Steuden
, Daniel Moffat
, Diana Gorog

Research output: Contribution to journal › Article › peer-review

41 Citations (Scopus)

Abstract

End-stage renal disease (ESRD) patients have an excess cardiovascular risk, above that predicted by traditional risk factor models. Prothrombotic status may contribute to this increased risk. Global thrombotic status assessment, including
measurement of occlusion time (OT) and thrombolytic status, may identify vulnerable patients. Our aim was to assess overall thrombotic status in ESRD and relate this to cardiovascular risk.

Original language	English
Pages (from-to)	354-363
Journal	European Heart Journal
Volume	34
Issue number	5
Early online date	9 Oct 2012
DOIs	https://doi.org/10.1093/eurheartj/ehs300
Publication status	Published - 2012

Access to Document

10.1093/eurheartj/ehs300

Cite this

@article{79017cab8ef54b87a5b6f4dfa1aa4c75,

title = "Impaired thrombolysis: a novel cardiovascular risk factor in end-stage renal disease",

abstract = "End-stage renal disease (ESRD) patients have an excess cardiovascular risk, above that predicted by traditional risk factor models. Prothrombotic status may contribute to this increased risk. Global thrombotic status assessment, including measurement of occlusion time (OT) and thrombolytic status, may identify vulnerable patients. Our aim was to assess overall thrombotic status in ESRD and relate this to cardiovascular risk.",

author = "Sumeet Sharma and Ken Farrington and Robert Kozarski and Christos Christopoulos and Maria Niespialowska-Steuden and Daniel Moffat and Diana Gorog",

year = "2012",

doi = "10.1093/eurheartj/ehs300",

language = "English",

volume = "34",

pages = "354--363",

journal = "European Heart Journal",

issn = "1522-9645",

publisher = "Oxford University Press (OUP)",

number = "5",

}

TY - JOUR

T1 - Impaired thrombolysis

T2 - a novel cardiovascular risk factor in end-stage renal disease

AU - Sharma, Sumeet

AU - Farrington, Ken

AU - Kozarski, Robert

AU - Christopoulos, Christos

AU - Niespialowska-Steuden, Maria

AU - Moffat, Daniel

AU - Gorog, Diana

PY - 2012

Y1 - 2012

N2 - End-stage renal disease (ESRD) patients have an excess cardiovascular risk, above that predicted by traditional risk factor models. Prothrombotic status may contribute to this increased risk. Global thrombotic status assessment, including measurement of occlusion time (OT) and thrombolytic status, may identify vulnerable patients. Our aim was to assess overall thrombotic status in ESRD and relate this to cardiovascular risk.

AB - End-stage renal disease (ESRD) patients have an excess cardiovascular risk, above that predicted by traditional risk factor models. Prothrombotic status may contribute to this increased risk. Global thrombotic status assessment, including measurement of occlusion time (OT) and thrombolytic status, may identify vulnerable patients. Our aim was to assess overall thrombotic status in ESRD and relate this to cardiovascular risk.

UR - http://www.scopus.com/inward/record.url?scp=84873330759&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/ehs300

DO - 10.1093/eurheartj/ehs300

M3 - Article

AN - SCOPUS:84873330759

SN - 1522-9645

VL - 34

SP - 354

EP - 363

JO - European Heart Journal

JF - European Heart Journal

IS - 5

ER -

Impaired thrombolysis: a novel cardiovascular risk factor in end-stage renal disease

Abstract

Access to Document

Other files and links

Fingerprint

Cite this